During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion

被引:177
作者
Hendriks, J
Xiao, YL
Rossen, JWA
van der Sluijs, KF
Sugamura, K
Ishii, N
Borst, J
机构
[1] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Virol, Utrecht, Netherlands
[3] Acad Med Ctr, Dept Pulm, Amsterdam, Netherlands
[4] Acad Med Ctr, Expt Immunol Lab, Amsterdam, Netherlands
[5] Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi 980, Japan
关键词
D O I
10.4049/jimmunol.175.3.1665
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Independent studies have shown that CD27, 4-1BB, and OX40 can all promote survival of activated CD8(+) T cells. We have therefore compared their impact on CD8+ memory T cell formation and responsiveness within one, physiologically relevant model system. Recombinant mice, selectively lacking input of one or two receptors, were challenged intranasally with influenza virus, and the immunodominant virus-specific CD8+ T cell response was quantified at priming and effector sites. Upon primary infection, CD27 and (to a lesser extent) 4-1BB made nonredundant contributions to accumulation of CD8(+) virus-specific T cells in draining lymph nodes and lung, while OX40 had no effect. Interestingly though, in the memory response, accumulation of virus-specific CD8+ T cells in spleen and lung critically depended on all three receptor systems. This was explained by two observations: 1) CD27, 4-1BB, and OX40 were collectively responsible for generation of the same memory CD8+ T cell pool; 2) CD27, 4-1BB, and OX40 collectively determined the extent of secondary expansion, as shown by adoptive transfers with standardized numbers of memory cells. Surprisingly, wild-type CD8(+) memory T cells expanded normally in primed OX40 ligand- or 4-1BB ligand-deficient mice. However, when wild-type memory cells were generated in OX40 ligand- or 4-1BB ligand-deficient mice, their secondary expansion was impaired. This provides the novel concept that stimulation of CD8(+) T cells by OX40 and 4-1BB ligand during priming imprints into them the capacity for secondary expansion. Our data argue that ligand on dendritic cells and/or B cells may be critical for this.
引用
收藏
页码:1665 / 1676
页数:12
相关论文
共 49 条
[1]  
ALSHAMKANI A, 1996, EUR J IMMUNOL, V151, P5261
[2]   Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation [J].
Arens, R ;
Schepers, K ;
Nolte, MA ;
van Oosterwijk, MF ;
van Lier, RAW ;
Schumacher, TNM ;
van Oers, MHJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1595-1605
[3]   Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion [J].
Arens, R ;
Tesselaar, K ;
Baars, PA ;
van Schijndel, GMW ;
Hendriks, J ;
Pals, ST ;
Krimpenfort, P ;
Borst, J ;
van Oers, MHJ ;
van Lier, RAW .
IMMUNITY, 2001, 15 (05) :801-812
[4]   Costimulation of CD8 T cell responses by OX40 [J].
Bansal-Pakala, P ;
Halteman, BS ;
Cheng, MHY ;
Croft, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4821-4825
[5]   Diversity of epitope and cytokine profiles for primary and secondary influenza A virus-specific CD8+ T cell responses [J].
Belz, GT ;
Xie, WD ;
Doherty, PC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4627-4633
[6]   A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo [J].
Bertram, EM ;
Dawicki, W ;
Sedgmen, B ;
Bramson, JL ;
Lynch, DH ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :981-988
[7]   Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection [J].
Bertram, EM ;
Lau, P ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3777-3785
[8]   Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions [J].
Chen, AI ;
McAdam, AJ ;
Buhlmann, JE ;
Scott, S ;
Lupher, ML ;
Greenfield, EA ;
Baum, PR ;
Fanslow, WC ;
Calderhead, DM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1999, 11 (06) :689-698
[9]  
Cooper D, 2002, EUR J IMMUNOL, V32, P521, DOI 10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO
[10]  
2-X